Thomas Marth - Concepedia

Author

Thomas Marth

National Institutes of Health

Also Known As

T Marth, T. MARTH, T. Marth, Thomas Marth, Thomas Marth Marth

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Institute of Allergy and Infectious Diseases Maria Hilf Krankenhaus Charité - Universitätsmedizin Berlin Saarland University

About

Thomas Marth is an author at National Institutes of Health specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.5K
2	Cell Biology	3	3	412
3	Allergy	2	2	86
4	Public Health	1	1	84
5	Gastroenterology	1	1	16

Thomas Marth

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Regulation of Interleukin-12 by Complement Receptor 3 Signaling Thomas Marth, Brian L. Kelsall The Journal of Experimental Medicine	1997	279
Expression of Interleukin-12-Related Cytokine Transcripts in Inflammatory Bowel Disease: Elevated Interleukin-23p19 and Interleukin-27p28 in Crohnʼs Disease But Not in Ulcerative Colitis Carsten Schmidt, Thomas Giese, Bianca Ludwig, Inflammatory Bowel Diseases	2005	277
Anti–interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice Ivan J. Fuss, Thomas Marth, Markus F. Neurath, Gastroenterology	1999	266
High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis Thomas Marth, Warren Strober, Brian L. Kelsall The Journal of Immunology	1996	221
Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. R A Seder, Thomas Marth, M C Sieve, PubMed Adaptive Immune SystemT-regulatory CellImmunologyPathologyImmunologic Mechanism	1998	203
Efficacy of Ceftriaxone or Meropenem as Initial Therapies in Whipple's Disease Gerhard E. Feurle, Natascha S. Junga, Thomas Marth Gastroenterology PharmacologyNeurologyMedicineInitial Therapies	2009	194
Factors Involved in the Differentiation of TGF-β-Producing Cells from Naive CD4+ T Cells: IL-4 and IFN-γ Have Opposing Effects, While TGF-β Positively Regulates Its Own Production Robert A. Seder, Thomas Marth, M C Sieve, The Journal of Immunology Tgf-β PositivelyTgf-β ProductionLymphocyte DevelopmentAdaptive Immune SystemImmune Regulation	1998	150
Immunosuppressive Therapy in Whipple's Disease Patients is Associated with the Appearance of Gastrointestinal Manifestations R. Mahnel, Anja Kalt, Sabine Ring, The American Journal of Gastroenterology	2005	137
Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease Thomas Marth, Markus F. Neurath, BA Cuccherini, Gastroenterology InflammationCytokineAutoimmune DiseaseMonocyte Interleukin 12Immunology	1997	130
An evaluation of antimicrobial treatment for whipple's disease Gerhard E. Feurle, Thomas Marth Digestive Diseases and Sciences Antimicrobial StewardshipAntibioticsAntimicrobial TreatmentInfection ControlMedicine	1994	123

Page 1